Zum Inhalt

HealthOSArzneimittel

Arbeitsbereiche

Nachschlagen

Wirkstoffe & Arzneimittelsicherheit

Exakte Wirkstoffkennungen und zitierbare Passagen zu Wechselwirkungen, Gegenanzeigen und Nebenwirkungen.

Ein Paarvergleich findet Originalpassagen, die den anderen Wirkstoff wörtlich nennen. Aussagen gelten für das jeweilige Präparat und seine Formulierung. Klassenbegriffe und abweichende Synonyme können fehlen. Kein Treffer bedeutet nicht, dass keine Wechselwirkung besteht.

RxNorm 05-Oct-2026 · geprüft 2026-10-27 · 1381 Präparate · 72104 Quellenpassagen · 204 strukturierte Aussagen. Automatisch aktualisiert, ohne menschliche Freigabe.

Quellenpassagen (1)

Wechselwirkungen · Amglidia

AMGLIDIA 0.6 mg/mL oral suspension AMGLIDIA 6 mg/mL oral suspension · Abschnitt 4.5 · PDF-Seite 8–10

HOS-226728 · Präparat HOS-217644

Anabolic steroids and male Potentiation of the Hypoglycaemia sex hormones blood-glucose lowering effect Barbiturates Weakening of the Increased blood-glucose blood-glucose lowering levels effect Beta-receptor blockers Potentiation of the Hypoglycaemia blood-glucose lowering effect Signs of adrenergic Incorrect control of plasma counter-regulation to glucose hypoglycaemia may be reduced or absent Biguanides Potentiation of the Hypoglycaemia blood-glucose lowering effect Bosentan Increase liver enzymes Incorrect control of plasma glucose Calcium channel blockers Weakening of the blood- Increased blood-glucose glucose-lowering effect levels Chloramphenicol Potentiation of the Hypoglycaemia blood-glucose lowering effect Cimetidine Weakening of the blood- Increased blood-glucose glucose lowering effect levels Clarithromycin Potentiation of the blood- Hypoglycaemia glucose lowering effect Clonidine Potentiation of the blood- Hypoglycaemia glucose lowering effect Potentiation or weakening of Incorrect control of plasma the blood-glucose lowering glucose effect Signs of adrenergic counter- Incorrect control of plasma regulation to hypoglycaemia glucose may be reduced or absent Weakening of the blood- Increased blood-glucose glucose lowering effect levels Colesevelam Reduction of glibenclamide Incorrect control of plasma absorption from the glucose gastrointestinal tract Corticosteroids Weakening of the blood- Increased blood-glucose glucose lowering effect levels Coumarin derivatives Potentiation of the blood- Hypoglycaemia glucose lowering effect Potentiate or weaken the Incorrect dose of coumarin effect of coumarin derivatives administered derivatives Cyclophosphamides Potentiation of the blood- Hypoglycaemia glucose lowering effect Diazoxide Weakening of the blood- Increased blood-glucose glucose lowering effect levels Disopyramide Potentiation of the blood- Hypoglycaemia glucose lowering effect Diuretics Weakening of the blood- Increased blood-glucose glucose lowering effect levels Fenfluramine Potentiation of the blood- Hypoglycaemia glucose lowering effect Fenyramidol Potentiation of the blood- Hypoglycaemia glucose lowering effect Fibrates Potentiation of the blood- Hypoglycaemia glucose lowering effect Fluoxetine Potentiation of the blood- Hypoglycaemia glucose lowering effect Glucagon Weakening of the blood- Increased blood-glucose glucose lowering effect levels Guanethidine Potentiation of the blood- Hypoglycaemia glucose lowering effect Signs of adrenergic counter- Incorrect control of plasma regulation to hypoglycaemia glucose may be reduced or absent H2-receptor antagonists Potentiation or weakening of Incorrect control of plasma the blood-glucose lowering glucose effect Heparin Potentiation of the blood- Hypoglycaemia glucose lowering effect Ifosfamide Potentiation of the blood- Hypoglycaemia glucose lowering effect Insulin Potentiation of the blood- Hypoglycaemia glucose lowering effect Isoniazid Weakening of the blood- Increased blood-glucose glucoselowering effect levels Large doses of laxatives Weakening of the blood- Increased blood-glucose glucose lowering effect levels Long-acting Potentiation of the blood- Hypoglycaemia sulphonamides glucose lowering effect MAO inhibitors Potentiation of the blood- Hypoglycaemia glucose lowering effect Miconazole Potentiation of the blood- Hypoglycaemia glucose lowering effect Nicotinic acid (in high Weakening of the blood- Increased blood-glucose doses) glucose lowering effect levels Oestrogens Weakening of the blood- Increased blood-glucose glucose lowering effect levels Other oral antidiabetics Potentiation of the blood- Hypoglycaemia glucose lowering effect Oxypentifylline Potentiation of the blood- Hypoglycaemia glucose lowering effect Oxyphenbutazone Potentiation of the blood- Hypoglycaemia glucose lowering effect Phenothiazine derivatives Weakening of the blood- Increased blood-glucose glucose lowering effect levels Phenytoin Weakening of the blood- Increased blood-glucose glucose lowering effect levels Phosphamides Potentiation of the blood- Hypoglycaemia glucose lowering effect Probenecid Potentiation of the blood- Hypoglycaemia glucose lowering effect Progestogens Weakening of the blood- Increased blood-glucose glucose lowering effect levels Quinolone antibiotics Potentiation of the blood- Hypoglycaemia glucose lowering effect Reserpine Potentiation of the blood- Hypoglycaemia glucose lowering effect Potentiation or weakening of Incorrect control of plasma the blood-glucose lowering glucose effect Signs of adrenergic counter- Incorrect control of plasma regulation to hypoglycaemia glucose may be reduced or absent Rifampicin Weakening of the blood- Increased blood-glucose glucose lowering effect levels Thyroid hormones Weakening of the blood- Increased blood-glucose glucose lowering effect levels Salicylates Potentiation of the blood- Hypoglycaemia glucose lowering effect Sulfamethoxazole with Potentiation of the blood- Hypoglycaemia trimethoprim (Co- glucose lowering effect trimoxazole) Tetracycline compounds Potentiation of the blood- Hypoglycaemia glucose lowering effect Tritoqualine Potentiation of the blood- Hypoglycaemia glucose lowering effect

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.

RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): sulfamethoxazole (HOS-084533) trimethoprim (HOS-085184) fenfluramine (HOS-115627) tetracycline (HOS-115153) cimetidine (HOS-085835) clonidine (HOS-088594) diazoxide (HOS-088588) glucose (HOS-088412) coumarin (HOS-088372) heparin (HOS-086930) ifosfamide (HOS-091529) calcium (HOS-085615) disopyramide (HOS-085595) clarithromycin (HOS-084517) probenecid (HOS-085208) tritoqualine (HOS-115631) fluoxetine (HOS-085946) chloramphenicol (HOS-115623) guanethidine (HOS-088596) bosentan (HOS-086291) colesevelam (HOS-112356) isoniazid (HOS-088590) reserpine (HOS-088597) phenytoin (HOS-084531) glucagon (HOS-088589) miconazole (HOS-115630) oxyphenbutazone (HOS-226734)

Vollständigen Kontext in der EMA-Fachinformation lesen →
Quellennachweis

Version 2023-12-06T13:39:00Z · SHA-256 9b31c8fd2e2c11b31d3834841c43620453c6c194a0c4f4a1689401e4cae4ff04 · Passage 65768f222638b6ec5b55799dedba422cfd4ab929c394f7deccb2b45b8e583e53 · Zeichen 3453–12347 im Abschnitt

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.